DJIA 16,712.63 251.31 1.53%
NASDAQ 4,456.29 73.44 1.68%
S&P 500 1,954.71 27.60 1.43%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)

69.51 0.73 (1.06%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AZN $69.51 1.06%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $69.04
Previous Close $68.78
Daily Range $68.95 - $69.45
52-Week Range $51.92 - $82.68
Market Cap $87.8B
P/E Ratio 33.72
Dividend (Yield) $1.80 (4.1%)
Ex-Dividend Date
Dividend Pay Date
08/13/14
09/15/14
Volume 331,542
Average Daily Volume 2,332,020
Current FY EPS $4.45

Sector

Healthcare

Industry

Drugs

AstraZeneca plc (ADR) (AZN) Description

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Website: http://www.astrazeneca.com/

News & Commentary

Is It Time to Buy Eli Lilly & Co.'s Stock?

Eli Lilly & Co. is promising big things, but has optimism in the stock gotten ahead of reality? It's time to ask if now's the right time to invest.

Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? - Analyst Blog

Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?

The world's largest pharmaceutical company, Pfizer, looks lost amid its staggering patent cliff problem. Could this experimental breast cancer drug put Pfizer back on track for growth?

Ironwood/Actavis Move Linzess into Phase II Study for OIC - Analyst Blog

Ironwood/Actavis Move Linzess into Phase II Study for OIC - Analyst Blog

AstraZeneca (AZN) Lagging In Pre-Market Activity

A Quick Look at Amgen, Inc.'s Drug Development Pipeline

Amgen's drug development pipeline is expected to deliver data on 10 late-stage candidates between 2014 and 2016. Find out what three studies are Amgen's most critical, as well as whether or not Amgen stock has the potential to head higher.

Today's Market: Inversions, Tech Deals And Upgrades/Downgrades Moving These Names

European Stocks Lower on Banking Contractions

AbbVie (ABBV) May Not Buy Shire (SHPG), But You Should

European Stocks Fall on Continued Worries Over Eurozone Economy

See More AZN News...

AZN's Top Competitors

AZN $69.51 (1.06%)
Current stock: AZN
JNJ $102.59 (1.35%)
Current stock: JNJ
NVS $89.38 (1.34%)
Current stock: NVS
RHHBY $36.63 (0.74%)
Current stock: RHHBY